Abstract: An object of the invention is to provide a bone filling material capable of promoting the bone regeneration effect of a growth factor such as platelet rich plasma (PRP). Inventors of the invention anticipated that the bone filling material adsorbs a growth factor like PRP, and the combined use of the bone filling material with PRP, the bone regeneration effect of PRP might be impaired. Further, the invention is basically related to the inhibition of this adsorbing effect of the bone filling material by using a capping agent. Since the adsorbing effect of the bone filling material is thus inhibited, PRP can exert the bone regeneration effect thereof in the case of using the bone filling material together with PRP.

Abstract: The objective of the invention is to provide a solution for tissue adhesion prevention and a method for tissue adhesion prevention that are applicable to general surgery and in which covering condition during surgery is stable and convenient. The invention is the solution for tissue adhesion prevention of which the active ingredient is trehalose. Also, it contains at least one or more among antioxidants, chelates, antiseptics, hemostatics, anti-inflammatory agents, and polysaccharides, mucopolysaccharides, salts of polysaccharides and salts of mucopolysaccharides having lubricating properties. This solution for tissue adhesion prevention is provided as any form of perfusion fluid, spray fluid, solution for spray or vaporization administration, foam-like aerosol preparation, injection solution for intravenous fluids, intravenous fluid.

Abstract: A liquid ejecting head includes: a plurality of head main bodies in which nozzle openings are arranged and manifolds communicate with the nozzle openings; and a passage member which includes a plurality of passages supplying a liquid supplied from an upstream side to the plurality of manifolds of the head main bodies. The plurality of head main bodies is disposed so that the manifolds are arranged in a first direction. The plurality of passages of the passage member includes a passage group in which an outflow port communicating with the manifold is disposed in the first direction and an inflow port to which the liquid is supplied from the upstream side is disposed in a second direction intersecting the first direction.

Abstract: An artificial bone forming method, comprising a) a powder layer forming step (32) for forming, into a flat powder layer (6), a powder bone material (5) having biocompatibility and hardening by hydration, b) a partial hardening step (34) for jetting an aqueous solution (7) with biocompatibility to a part of the powder layer to harden a jetted portion (6a) by hydration, and c) an artificial bone forming step (36) for repeating the steps a) and b) for lamination to form a specified artificial bone (9) of a predetermined three-dimensional structure in which the hardened portions (6a) are connected to each other.

Abstract: An object of the present invention is to provide a tissue cell culture system whereby a call tissue can be efficiently and quickly proliferated in vivo and the onset bacterial infection in an injured part can be avoided in the course of a treatment. More specifically, a closed cell culture system (1) characterized in that a defection (2) of a tissue on the body surface or inside the body is tightly sealed to form a closed environment free from the invasion of bacteria, etc. and then a solution appropriate for cell culture is circulated in the tissue defection thus sealed to thereby regenerate the defective tissue; and a method of administering a drug which comprises dissolving a remedy in the perfusion with the use of the above system and thus promoting the treatment of the defection.

Abstract: A novel method for producing a bone filling material is provided. The method comprises the steps of: (a) kneading ingredient comprising calcium-based material and material comprising binder; (b) molding a predetermined shape of the mixture obtained in step (a) with an injection molding machine having a mold; (c) removing the binder contained in the mold formed in step (b) (i.e., degreasing) to obtain a degreased body; (d) and heating and sintering the degreased body obtained in step (c) to obtain a sintered body.

Abstract: A liquid ejecting head unit including liquid ejecting head bodies for ejecting liquid by the drive of a pressure generating device; wiring members for feeding drive signals to the pressure generating device of the liquid ejecting head bodies; and connector members provided at an end of the wiring members, being connected by the wiring members, and having second connector sections detachable from first connectors of the liquid ejecting head bodies; wherein the connector members respectively include a base member equipped with a wiring member connector for inserting the connecting end of the wiring member for connection, and a retaining member fixed to the base member covering the wiring member connector section; wherein the wiring members inserted into the wiring member connector are retained in a folded state by the retaining members.

Abstract: It is an object of the present invention to provide a gel-forming composition which permits on-site administration and can form a gel exhibiting prescribed strength and sustained drug release, devices for the administration thereof, and a kit for medical use. A gel-forming composition which is composed of the first composition comprising a drug, a first gelling agent represented by the general formula (I) and the like, and the first diluent and the second composition comprising the second gelling agent represented by the general formula (I) and the like and the second diluent; and application devices and kits for medical use, which can hold the gel-forming composition. X1—(OCH2CH2)n—X2 (I) wherein X1 and X2 are each —R1COONHS (wherein R1 is C1-7 alkylene), —COR1COONHS, —NOCOR1—R2 (wherein R2 is maleimido), —R1NH2, —R1SH, or —CO2PhNO2, and n is an integer of 80 to 1000.

Abstract: A liquid ejecting head unit includes: a liquid ejecting head which includes a nozzle row formed by nozzles arranged in series so as to eject a liquid onto a printing medium; and a base plate which retains the liquid ejecting head, wherein a linear expansion coefficient of the base plate in a first direction as a relative moving direction between the printing medium and the liquid ejecting head is larger than that in a second direction perpendicular to the first direction.

Abstract: An artificial bone forming method, comprising a) a powder layer forming step (32) for forming, into a flat powder layer (6), a powder bone material (5) having biocompatibility and hardening by hydration, b) a partial hardening step (34) for jetting an aqueous solution (7) with biocompatibility to a part of the powder layer to harden a jetted portion (6a) by hydration, and c) an artificial bone forming step (36) for repeating the steps a) and b) for lamination to form a specified artificial bone (9) of a predetermined three-dimensional structure in which the hardened portions (6a) are connected to each other.

Abstract: A method for producing a bone filler basically comprising: a bone model producing step (step 1) for producing a bone model; a figure forming material filling step (step 2) for filling a figure forming material into a bone defect site of the bone model obtained in the bone model producing step; and a bone filler producing step (step 3) for producing a bone filler which is to be filled in a bone defect site based on the figure forming material filled in the bone defect site of the bone model in the figure forming material filling step.

Abstract: An object of the present invention is to provide an agent for treating or preventing vasospasm. An object of the present invention is to provide an agent for treating or preventing cerebral vasospasm as well as arterial vasospasm. Further, an object of the present invention is to provide an agent for treating or preventing cerebral ischemia and cerebral infarction. The above problems are solved by an agent for treating and preventing vasospasm, cerebral ischemia, or cerebral infarction, comprising trehalose as the active ingredient. It is possible, by using such a trehalose-comprising agent, to suppress phenomena such as contraction of blood vessel and thickening of tunica intima and tunica media and to prevent or treat vasospasm and vasospasm-dependent diseases.

Abstract: A bone filling material having controlled release of a pharmaceutical agent such as a growth factor, and a drug release controlling carrier having controlled release of a pharmaceutical agent is provided by inactivating a functional group which can strongly bind to the pharmaceutical agent of the bone filling material with a blocking agent. The bone filling material and the drug release controlling carrier of the present invention comprises: a calcium-based material such as hydroxyapatite, carbonate apatite, fluorapatite, chlorapatite, ?-TCP, and ?-TCP; a blocking agent of the calcium-based material such as serine and dextran; and a pharmaceutical agent.

Abstract: It is an object of the present invention to provide a figure-forming composition which enables the initiation of hardening even with a small amount of water and can attain a prescribed hardness, and which is suitable particularly for the production of three-dimensional living body models for surgical training by a rapid prototype process; and provide a three dimensional figure and a three-dimensional structure which are formed by using the composition. The figure-forming composition, for example, comprises a calcium-based material such as hemihydrate gypsum and polyvinyl alcohol resin, wherein the content of the polyvinyl alcohol resin is 2 to 20 weight parts when the total weight of the calcium-based material and the polyvinyl alcohol resin is 100 weight parts.

Abstract: A vehicle height adjusting apparatus includes air spring portion, an air supply source, a switching valve causing a total air volume of the air spring portion to be constituted by only a main air chamber and by a sum of the main air chamber and a sub air chamber, an auxiliary valve, operating state determining portion for determining an operating state of the vehicle, and controlling portion for controlling the adjusting valve, the switching valve and the auxiliary valve.

Abstract: A pipe capable of eliminating the adverse influence of a cavity flow on a branch pipe is provided. In a pipe 1 which is branched from a main pipe 3 through which a high-temperature fluid flows and which is configured to be closable, dividing part 5, 7, and 9 are provided in the pipe 1 for dividing a channel in the pipe 1 into a plurality of small channels.

Abstract: The objective of the invention is to provide a solution for tissue adhesion prevention and a method for tissue adhesion prevention that are applicable to general surgery and in which covering condition during surgery is stable and convenient. The invention is the solution for tissue adhesion prevention of which the active ingredient is trehalose. Also, it contains at least one or more among antioxidants, chelates, antiseptics, hemostatics, anti-inflammatory agents, and polysaccharides, mucopolysaccharides, salts of polysaccharides and salts of mucopolysaccharides having lubricating properties. This solution for tissue adhesion prevention is provided as any form of perfusion fluid, spray fluid, solution for spray or vaporization administration, foam-like aerosol preparation, injection solution for intravenous fluids, intravenous fluid.

Abstract: An object is to prevent thermal fatigue, resulting from variations in temperature interfaces, of piping having a fluid-mixing region where fluids of different temperatures are mixed. Piping 1 having a fluid-mixing region M includes a reducer 5 including an end portion 5e disposed substantially on a central axis of a main pipe 2. Low-temperature water flows through the reducer 5 at a lower velocity than high-temperature water flowing outside the end portion 5e. The low-temperature water and the high-temperature water have different temperatures. The low-temperature water and the high-temperature water are mixed in the fluid-mixing region M downstream of the reducer 5. The reducer 5 has a weld line 5f formed to connect the end portion 5e and an elbow portion 5d together. The distance between the weld line 5f and a downstream end 5a is equal to or larger than the inner diameter D of the main pipe 2.

Abstract: A method of administering a drug whereby a fine drug powder can be accurately administered to a target site (in particular, a target site in the body cavity) via fluidization and spraying with a gas by using a micro tube. Concerning the administration mode, in particular, the drug alone or a biopolymer is administered or the biopolymer is employed as a carrier in the above method. More specifically speaking, a method of administering a fine drug powder which comprises finely milling one or more types fine particles of the drug and/or the biopolymer, blending them each other, fluidizing the blend with a gas, then transporting the fluidized matter in a micro tube by the gas stream and spraying the fine drug powder from the tip of the micro tube toward the target site.

Abstract: A fluid ejecting head includes a fluid storage chamber that temporarily stores a fluid, which is supplied from a fluid supply port, a plurality of pressure chambers, to which the fluid stored in the fluid storage chamber is supplied through a plurality of fluid supply paths, respectively, a plurality of driving elements that change pressure in the pressure chambers, respectively, and a plurality of nozzle openings, from which the fluids contained in the pressure chambers are ejected when the driving elements are driven, respectively. A specific driving element most distant from the fluid supply port among the driving elements has a maximum capability to discharge the air bubbles in the fluid from the nozzle opening among the driving elements.